Literature DB >> 19189879

Behavioral changes in G72/G30 transgenic mice.

David M Otte1, Andras Bilkei-Gorzó, Michaela D Filiou, Christoph W Turck, Oznur Yilmaz, Martin Ingo Holst, Karl Schilling, Rami Abou-Jamra, Johannes Schumacher, Isabel Benzel, Wolfram S Kunz, Heinz Beck, Andreas Zimmer.   

Abstract

Genetic studies have implicated the evolutionary novel, primates-specific gene locus G72/G30 in schizophrenia, bipolar and panic disorders. It encodes for a protein LG72 whose function has been controversially discussed as putative regulator of the peroxisomal enzyme D-amino-acid-oxidase (DAO), or as a mitochondrial protein, which promotes robust mitochondrial fragmentation in mammalian cell lines including human and rat primary neurons. Because of this conserved function we here have generated "humanized" BAC transgenic mice (G72Tg) expressing alternatively spliced G72 and G30 transcripts, and the LG72 protein. G72 expression is prominent in granular cells of the cerebellum, the hippocampus, the cortex and the olfactory bulb. Most strikingly, G72Tg mice displayed deficits in sensorimotor gating which could be reversed with haloperidol, increased sensitivity to PCP, motor-coordination deficits, increased compulsive behaviors and deficits in smell identification. These results demonstrate that expression of the human G72/G30 gene locus in mice produces behavioral phenotypes that are relevant to psychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19189879     DOI: 10.1016/j.euroneuro.2008.12.009

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  28 in total

Review 1.  Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders.

Authors:  Susan B Powell; Martin Weber; Mark A Geyer
Journal:  Curr Top Behav Neurosci       Date:  2012

2.  Genetic variation in G72 correlates with brain activation in the right middle temporal gyrus in a verbal fluency task in healthy individuals.

Authors:  Axel Krug; Valentin Markov; Sören Krach; Andreas Jansen; Klaus Zerres; Thomas Eggermann; Tony Stöcker; N Jon Shah; Markus M Nöthen; Alexander Georgi; Jana Strohmaier; Marcella Rietschel; Tilo Kircher
Journal:  Hum Brain Mapp       Date:  2011-01       Impact factor: 5.038

Review 3.  G72 primate-specific gene: a still enigmatic element in psychiatric disorders.

Authors:  Silvia Sacchi; Giorgio Binelli; Loredano Pollegioni
Journal:  Cell Mol Life Sci       Date:  2016-02-25       Impact factor: 9.261

4.  Mutant mouse models: genotype-phenotype relationships to negative symptoms in schizophrenia.

Authors:  Colm M P O'Tuathaigh; Brian P Kirby; Paula M Moran; John L Waddington
Journal:  Schizophr Bull       Date:  2009-11-24       Impact factor: 9.306

5.  Chronic nicotine improves short-term memory selectively in a G72 mouse model of schizophrenia.

Authors:  B Hambsch; H Keyworth; J Lind; D M Otte; I Racz; I Kitchen; A Bailey; A Zimmer
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 6.  Avoiding mouse traps in schizophrenia genetics: lessons and promises from current and emerging mouse models.

Authors:  M Kvajo; H McKellar; J A Gogos
Journal:  Neuroscience       Date:  2011-07-27       Impact factor: 3.590

7.  N-acetyl cysteine treatment rescues cognitive deficits induced by mitochondrial dysfunction in G72/G30 transgenic mice.

Authors:  David-Marian Otte; Britta Sommersberg; Alexei Kudin; Catalina Guerrero; Onder Albayram; Michaela D Filiou; Pamela Frisch; Oznur Yilmaz; Eva Drews; Christoph W Turck; Andras Bilkei-Gorzó; Wolfram S Kunz; Heinz Beck; Andreas Zimmer
Journal:  Neuropsychopharmacology       Date:  2011-06-29       Impact factor: 7.853

Review 8.  Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia.

Authors:  Hayley B Clay; Stephanie Sillivan; Christine Konradi
Journal:  Int J Dev Neurosci       Date:  2010-09-15       Impact factor: 2.457

Review 9.  Pre-clinical models of neurodevelopmental disorders: focus on the cerebellum.

Authors:  Alexey V Shevelkin; Chinezimuzo Ihenatu; Mikhail V Pletnikov
Journal:  Rev Neurosci       Date:  2014       Impact factor: 4.353

Review 10.  The neurobiology of D-amino acid oxidase and its involvement in schizophrenia.

Authors:  L Verrall; P W J Burnet; J F Betts; P J Harrison
Journal:  Mol Psychiatry       Date:  2009-09-29       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.